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Introduction
Atrial fibrillation (AF) is the most common cardiac 
arrhythmia and increases the risk of  stroke and 
death.  Several atherosclerotic risk factors, such as 
obesity, diabetes and hypertension, are associated with 
development of  AF. (1-3)  Many studies have shown 
that individuals with hypertension have an increased 
risk of  developing atrial fibrillation compared with 
normotensive individuals.(4-6) Several inflammatory 
markers such as C-reactive protein (CRP), tumor 
necrosis factor-α  (TNF-α) , interleukin (IL)-2, IL-6, 
IL-8, and monocyte chemo attractant protein     
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(MCP)-1 and mediators   have been shown  associated 
with the presence or the outcome of  AF.(7)  A growing 
body of  literature supports a role for the immune 
system and chronic inflammation in the development of  
hypertension.(8; 9)   Red blood cell distribution width 
(RDW) is a measurement of  the variability in size of  
circulating erythrocytes. RDW is obtained routinely in 
standard complete blood cell counts (CBCs). Increased 
RDW indicates the presence of  anisocytosis, which 
is related  to impaired erythropoiesis and erythrocyte 
degradation, reflecting chronic inflammation and a high 
level of  oxidative stress.(10-12)   Recent studies have 
reported that RDW levels are elevated in cardiovascular 
disorders including heart failure, stable coronary disease, 
acute coronary syndrome, slow coronary flow  and in 
non-cardiovascular diseases, stroke.(13-17)
However, to the best of  our knowledge, to evaluate 
the relation between RDW and AF in patients with 
hypertensive has not been reported in the literature 
previously. In this study, we aimed to investigate 
the relation between RDW and AF in patients with 
hypertensive
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Abstract
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia and increases the risk of  stroke and death. 
Patients with hypertensive have an increased risk of  developing atrial fibrillation. RDW (Red blood cell distribution width) 
levels are elevated in cardiovascular disorders including heart failure, stable coronary disease, acute coronary syndrome, slow 
coronary flow and stroke. 
Objective: We aimed to investigate the relation between RDW and AF in patients with hypertensive
Method: We retrospectively examined 126 consecutive hypertensive patients (63 hypertensive patients with AF and 63 hy-
pertensive patients without AF matched with age and sex
Results: The mean age of  the study population was 71,09± 8,50 (af  group) and 70,97±8,24 (non-af  group) years. RDW 
level was different among patients with atrial fibrillation and without atrial fibrillation.(15,13±1,58 and 14,05±1,15 p<001) . 
Logistic regression analysis showed that RDW and left atrial dimension were only independently risk factory associated with 
atrial fibrillation. (Rdw odds ratio:1,846 CI; 1,221-2,793 p<0,05). Roc curve analyses were applied to determine the cut-off  
point. Cut-off  point was at 14,195 and Sensitive, specificity was %71,4, %56 respectively.
Conclusion: RDW levels were higher in hypertensive patients with atrial fibrillation. An increased RDW level in the patient 
with hypertension may alert physician on developing or presence of  atrial fibrillation.
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Method
Patient selection
We retrospectively examined 126 consecutive hyper-
tensive patients (63 hypertensive patients with AF and 
63 hypertensive patients without AF matched with age 
and sex) at university of  Bozok and GOP. All patients’ 
records of  history and physical examinations were ex-
amined in detail.  No patient had a recent history of  
an acute infection or an inflammatory disease. Patients 
with renal failure, concomitant valvular disease, cardio-
myopathy, and previous cardiac surgery and seconder 
hypertension were excluded.
Echocardiographic assessment
Transthoracic 2-dimensional and Doppler 
echocardiographic assessment was performed. (Aloca, 
Japon). Measurements of  the left atrium, left ventricle 
and right ventricle was obtained from parasternal long 
axis view according to standard criteria. Left ventricular 
ejection fraction (LVEF) was calculated using the 
modified Simpson’s rule in the 2- and 4-chamber apical 
views.
Measurement of   laboratory parameters
On admission, venous bloods were obtained from the 
antecubital vein from all patients after fasting for at least 
8 h. Fasting plasma glucose (FBG), creatinine, plasma 
levels of  total cholesterol (TC), low-density lipoprotein 
(LDL), high-density lipoprotein (HDL) cholesterol and 
triglyceride (TG)  were determined by a hospital auto 
analyzer. CBC analysis including RDW was performed 
with Beckman Coulter LH 750 automated analyzer 
within 2 h.
Statistic
The statistical analyses were performed using 
software (SPSS 18.0). Parametric values were given as 
mean±standard deviation and non-parametric values 
were given as a percentage. To compare parametric 
continuous variables, Student’s t-test  was used; to 
compare nonparametric continuous variables, the 
Mann–Whitney U-test was used. Categorical data were 
compared by Chi-square distribution. Receiver operator 
characteristic (ROC) curve analysis was performed to 
identify the optimal cut-off  point of  RDW (at which 
sensitivity and specificity would be maximal)  for the 
prediction of  AF. Areas under the curve (AUC) were 
calculated as measures of  the accuracy of  the tests. We 
compared the AUC with the use of  the Z test.  Variables 
found to be statistically significant in univariate analyses 
were entered into multivariate logistic regression analysis 
.Multivariate logistic regression models were created 
to identify independent predictors of  AF. Two-tailed 
P-values of  less than 0.05 were considered to indicate 
statistical significance. 
Results
There were no significant differences among patients 
with or without atrial fibrillation in terms of  gender, 
age, coronary artery disease, diabetes Mellitus. The 
mean age of  the study population was 71,09± 8,50 (af  
group) and  70,97±8,24 (non-af  group) years.  LVEF 
and left atrium dimensions (LAD) TG,TC,and RDW 
levels were different  between the two  groups (Table 
1). 
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Table 2. Multivariate regression analyses
Table 2: Independent predictors of  atrial fibrillation in multivariate logistic regression analysis                                       
Odds ratio CI P value
RDW 1,846 1,221-2,793 0,004
EF 0,914 0,835-1,004 0,06
LAD 6,985 2,451-19,904 0,001
TC 0,992 0,982-1,002 0,137
TG 1,000 0,993-1,006 0,904
RDW: Red Blood Cell Distribution Width EF: Ejection Fraction LAD: Left Atrial Diameter TC: Total Cholesterol TG: 
Triglyceride
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Table 1. Baseline characteristics of  patients

















Glucose 108,178±29,354 112,05±33,80 0,855
Creatinin 1,16±1,21
0,90±0,23 0,314
TG 115,03±70,97 154,05±105,68 0,023
TC 170,26±46,13 214,81±80,86 0,002
HDL 42,85±8,26 44,83±16,75 0,140
LDL 106,11±31,91 123,94±43,28 0,28
RDW 15,13±1,58 14,05±1,157 0,001
HB 13,74±1,38 13,88±1,62 0,323
EF% 52,68±8,20 57,98±4,84 0,001
LAD 4,43±0,78 3,8±0,27 0,001
Dm:diabetes mellitus CAD:coronary artery disease TG:Triglyceride TC:Total cholesterol HDL:High Density Cholesterol 
LDL:Low Density Cholesterol RDW: Red Blood Cell Distribution Wide Hb:Hemoglobin EF:Ejection fraction LAD: Left 
Atrial Diameter
The patient with AF had less EF (%52,68±8,20 
and 57,98±4,84 p<0,05) and LAD (4,43±0,78 and 
3,8±0,27 p<0,05) than non-atrial fibrillation group. 
TC (170,26±46,13 and 214,81±80,86 p<0,05),TG( 
115,03±70,97and 154,05±105,68 p<0,05) and Hb 
(13,23±1,32 and 13,67±1,79 p<0,05) were different 
between patients with or without atrial fibrillation 
respectively. (Table 1) RDW level was different among 
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patients with atrial fibrillation and without atrial 
fibrillation.(15,13±1,58 and 14,05±1,15 p<001) (table 
1). Variables found to be statistically significant in 
univariate analyses were entered into multivariate logistic 
regression analysis.multivariate Logistic regression 
analysis showed that  RDW and left atrial dimension 
were only independently risk factory associated with 
atrial fibrillation. (Rdw odds ratio:1,846 CI; 1,221-2,793 
p<0,05) (table 2). 
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Roc curve analyses were applied to determine the cut-off  point.(Figure 1) Cut-off  point was at 14,195 and Sensitive, 
specificity was %71,4, %56 respectively.
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Figure 1. ROC curve analysis of  RDW
Discussion
Our study showed that an increased RDW level was 
independently associated with atrial fibrillation in the 
patient with hypertension. The cut of  point of  14,195 
levels was a strong predictor of  atrial fibrillation in the 
patient with hypertension. The sensitive, specificity was 
%71,4 and  %56 respectively. 
Many studies have shown that individuals with 
hypertension have an increased risk of  developing atrial 
fibrillation compared with normotensive individuals.
(4-6) Elevated systolic blood pressure is associated with 
increases in left atrial fibrosis,(18; 19) which in turn is 
related to prevalent atrial fibrillation. (20)  Some studies 
suggest that left ventricular hypertrophy and increases in 
left atrial size may also mediate the relationship between 
blood pressure and incident atrial fibrillation.(21; 22)  
In our study, LAD was higher in patient with hypertensive 
patients with AF that those without AF. Anatomic 
evidence of  inflammation ,such as myocyte necrosis, 
inflammatory infiltrates and fibrosis have been shown 
in the atrial wall in biopsies of  patient with persistent.
(23)  Several inflammatory markers such as CRP,TNF-α 
,IL-2, IL-6, IL-8, and MCP-1 and mediators   have been 
shown associated with the presence or the outcome of  
AF. (7)  Patients with high baseline CRP levels are at 
higher risk of  having postoperative atrial fibrillation in 
both on-pump and off-pump surgery.(24)
RDW is a numerical  measure of  the size variability of  
circulating erythrocytes and is routinely reported as a 
component of  complete blood count in the differential 
diagnosis of  anemia Studies recently  have shown that 
RDW was  strong and independent predictor of  poor 
outcome in the general population.(25)  RDW has 
been recently reported that being predictive of  poor 
outcome in several cardiovascular disease including 
heart failure, stable coronary artery disease and acute 
myocardial infarction.(7; 15; 26; 27) The mechanism 
of  elevated RDW values are unknown that why it is 
linked with adverse outcomes. Some studies has been 
suggested that RDW may  reflect prognostic markers in 
heart failure, such as inflammatory cytokines that may 
affect bone marrow function and iron metabolism.(28; 
29) Agarwal and at all. have demonstrated that subjects 
with low cardiorespiratory fitness have elevated RDW 
by virtue of  chronic inflammation and high oxidative 
stress, which is likely to promote atherosclerosis and 
lead to cardiovascular disease.(19)  
A growing body of  literature supports a role for the 
immune system and chronic inflammation in the 
development of  hypertension.(8; 9) Higher RDW values 
were strongly correlated with higher systolic and diastolic 
blood pressures.(30) RDW was significantly increased 
in patients with non-dipper hypertension compared 
with the dipper hypertension. Inflammatory activity 
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was closely related to RDW in non-dipper hypertensive 
patient.(31)  In present study, Increased RDW, as a 
surrogate marker of  inflammation, was associated with 
atrial fibrillation in the patient with hypertensive. 
Inflammatory activity is increased in the patient with 
hypertension. Also, inflammatory activity plays a major 
role in the presence and developing of  atrial fibrillation. 
RDW is new inflammatory marker. Therefore, developing 
of  atrial fibrillation in the patient with hypertension may 
not only associated with diastolic dysfunction also may 
be related to inflammation but why RDW is increased 
in the patient with atrial fibrillation with hypertensive is 
not clear.
However, best of  our knowledge to evaluate the relation 
between RDW and AF in patients with hypertensive 
has not been reported in the literature previously. The 
present study revealed that RDW levels were higher 
in hypertensive patients with AF than that those 
without AF. Incidence of  hypertension is high in the 
general population. Developing atrial fibrillation in this 
patient may poorly affect prognosis of  the patient. An 
increased RDW level in the patient with hypertension 
may alert physician on developing or presence of  atrial 
fibrillation.
Conclusion 
RDW levels were higher in hypertensive patients with 
AF than that those without AF. An increased RDW lev-
el in the patient with hypertension may alert physician 
on developing or presence of  atrial fibrillation.
Limitations
The main limitation of  our study was the small sample 
size. A small sample size can result in a low statistical 
power for equivalency testing, leading to false-negative 
results. Second, because of  the retrospective nature of  
data collection, echocardiographic parameters were not 
obtained concomitantly with blood sampling. Also, we 
were unable to evaluate some factors, such as Vitamin 
B12, ferritin that have been effected to the RDW, be-
cause data on these variables were not collected and we 
cannot apply our results for general population due to 
the broad exclusion criteria.
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